Position in NUVB
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$10,223,202
New position
Shares Held
2,383,031
first reported quarter
Ownership
0.684%
of shares outstanding
% of Portfolio
2.19%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Jones Hill Capital LP holds $419,748,394 across 24 Biotechnology names. NUVB ranks #13 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMRN |
Biomarin Pharmaceutical Inc
|
1,268,390 | $71,651,351 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
108,603 | $48,495,583 | |
| 3 | PCVX |
Vaxcyte, Inc.
|
644,831 | $37,471,129 | |
| 4 | NUVL |
Nuvalent, Inc.
|
300,830 | $30,820,033 | |
| 5 | CAPR |
Capricor Therapeutics, Inc.
|
909,207 | $27,639,892 | |
| 6 | TERN |
Terns Pharmaceuticals, Inc.
|
521,237 | $27,479,614 | |
| 7 | BCAX |
Bicara Therapeutics Inc.
|
1,260,136 | $25,064,105 | |
| 8 | RARE |
Ultragenyx Pharmaceutical Inc.
|
1,165,557 | $24,418,419 |
All Filings in NUVB
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,223,202 | 2,383,031 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||